Recursion Pharmaceuticals, Inc. (RXRX)

NMS – Real Time Price. Currency in USD

3.15

-0.11 (-3.37%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

75M

59M

45M

40M

Cost of goods sold

-121M

-63M

-51M

-49M

Gross Profit

-46M

-5M

-7M

-9M

Operating expenses (excl. COGS)

-602M

-474M

-344M

-237M

Operating Income

-648M

-479M

-350M

-246M

Non-operating income, total

14M

18M

Pretax income

-645M

-465M

-332M

-239M

Equity in earnings

Taxes

136K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-645M

-464M

-328M

-239M

Recursion Pharmaceuticals, Inc. (RXRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Recursion Pharmaceuticals, Inc. (RXRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Recursion Pharmaceuticals, Inc. (RXRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Recursion Pharmaceuticals, Inc. (RXRX)

Income Statement (Annual)

Income Statement (Annual)